Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03724305 · ClinicalTrials.gov registry record · NA
Reduce Emotional Symptoms of Insomnia With SleepTreatment
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03724305 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 21 participants.
The verdict
NCT03724305, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this research is to test whether Mindfulness-Based Therapy for Insomnia (MBTI) significantly reduces symptoms of insomnia and cognitive arousal in patients with treatment-resistant insomnia.
Interventions
- BEHAVIORAL Mindfulness-Based Therapy for Insomnia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2023-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03724305
The ClinicalTrials.gov registry entry for NCT03724305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mindfulness-Based Therapy for Insomnia is the first listed.
NCT03724305 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03724305 about?
NCT03724305 is a clinical study titled "Reduce Emotional Symptoms of Insomnia With SleepTreatment". The purpose of this research is to test whether Mindfulness-Based Therapy for Insomnia (MBTI) significantly reduces symptoms of insomnia and cognitive arousal in patients with treatment-resistant insomnia.
What is the current status of trial NCT03724305?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-09-01. Estimated completion is 2023-03-08.
What interventions are being tested in trial NCT03724305?
The interventions under investigation include: Mindfulness-Based Therapy for Insomnia (BEHAVIORAL).
Who is sponsoring clinical trial NCT03724305?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.